Former US president Jimmy Carter was treated with immunotherapy for cancer. Immunotherapy has had a rocky road of research over the years.
Immunotherapy can be an effective treatment against cancer. But over the past 30 years, research into immunotherapy has nearly been abandoned several times. And if no one had ever picked it back up, it might have been bad news for former US president Jimmy Carter.
Last August, Carter announced he had stage IV metastatic melanoma, and that it had spread to his brain. When he first got the diagnosis, he thought he might have only “a few weeks left,” he said, but by the time of his press conference, he was more optimistic. Carter would soon undergo surgery and radiation treatment, and would also receive regular doses of pembrolizumab, an immunotherapy drug that had been approved by the Food and Drug Administration (FDA) to treat melanoma less than a year earlier.
And four days ago, after about three and a half months of treatment, Carter announced that his cancer was gone.
Read Full Article: The tumultuous history of the drugs that helped cure Jimmy Carter – Quartz